Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients have an impaired urine concentrating capacity. Increased circulating vasopressin (AVP) concentrations are supposed to play a role in the progression of ADPKD. We hypothesized that ADPKD patients have a more severely impaired urine concent...
Main Authors: | Debbie Zittema, Niek F Casteleijn, Stephan J L Bakker, Lianne S M Boesten, A A Margreeth Duit, Casper F M Franssen, Carlo A J M Gaillard, Ron T Gansevoort |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5231267?pdf=render |
Similar Items
-
The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels
by: Esmée M. Ettema, et al.
Published: (2017-05-01) -
Arginine vasopressin and copeptin in perinatology
by: Katrina Suzanne Evers, et al.
Published: (2016-08-01) -
Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
by: Esmée M Ettema, et al.
Published: (2015-01-01) -
Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes
by: A. Nesen, et al.
Published: (2022-06-01) -
Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
by: North WG
Published: (2023-11-01)